NF-κB Pathway Inhibitors Preferentially Inhibit Breast Cancer Stem-Like Cells

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-007-9798-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sulforaphane Sensitizes Human Breast Cancer Cells to Paclitaxel‑induced Apoptosis by Downregulating the NF‑κB Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway

PLoS ONE
Multidisciplinary
2016English

NF-κB Signaling Pathway, Inflammation and Colorectal Cancer

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2009English

Variable NF-κB Pathway Responses in Colon Cancer Cells Treated With Chemotherapeutic Drugs

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

The TGFβ-miR-499a-SHKBP1 Pathway Induces Resistance to EGFR Inhibitors in Osteosarcoma Cancer Stem Cell-Like Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Non-Canonical NF-κB Signaling Pathway

Cell Research
Cell BiologyMolecular Biology
2010English

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy via Suppressing WNT/Β-Catenin Signaling Pathway

PLoS ONE
Multidisciplinary
2014English

Nuclear Reprogramming of Luminal-Like Breast Cancer Cells Generates Sox2-Overexpressing Cancer Stem-Like Cellular States Harboring Transcriptional Activation of the mTOR Pathway

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2013English

Breast Cancer Stem Cells

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy